Lexeo Therapeutics Inc. C... (LXEO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
5.46
-0.34 (-5.86%)
At close: Jan 15, 2025, 3:59 PM
5.49
0.55%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -66.39M | -59.28M | -50.62M | -5.15M |
Depreciation & Amortization | 1.84M | 1.15M | 13.00K | n/a |
Stock-Based Compensation | 3.04M | 1.78M | 386.00K | n/a |
Other Working Capital | 1.66M | 2.22M | 3.03M | 105.83K |
Other Non-Cash Items | 530.00K | 4.50M | -2.60M | 1.87M |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.48M | 1.79M | 6.04M | 150.15K |
Operating Cash Flow | -59.50M | -54.56M | -44.18M | -3.13M |
Capital Expenditures | -165.00K | -901.00K | -188.00K | n/a |
Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -50.00K | n/a | n/a | n/a |
Investing Cash Flow | -165.00K | -901.00K | -188.00K | n/a |
Debt Repayment | 3.58M | -163.00K | n/a | 2.60M |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -35.00K | 352.00K | 150.86M | 29.78M |
Financial Cash Flow | 103.79M | 189.00K | 150.86M | 32.38M |
Net Cash Flow | 44.13M | -55.27M | 106.49M | 29.25M |
Free Cash Flow | -59.66M | -55.46M | -44.37M | -3.13M |